{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T17:39:36Z","timestamp":1792777176990,"version":"4.5.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:00:00Z","timestamp":1792713600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:00:00Z","timestamp":1792713600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100000155","name":"Social Sciences and Humanities Research Council of Canada","doi-asserted-by":"publisher","award":["430-2015-00712"],"award-info":[{"award-number":["430-2015-00712"]}],"id":[{"id":"10.13039\/501100000155","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Health Econ"],"DOI":"10.1007\/s10198-026-02004-4","type":"journal-article","created":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T04:32:59Z","timestamp":1792729979000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Health state values in cancer patients and the general population: evidence from SF-6Dv2"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7017-096X","authenticated-orcid":false,"given":"Thomas G.","family":"Poder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hosein","family":"Ameri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,23]]},"reference":[{"key":"2004_CR1","doi-asserted-by":"publisher","DOI":"10.34172\/ijhpm.8404","volume":"13","author":"H Ameri","year":"2024","unstructured":"Ameri, H., and T.G. Poder. 2024. Valuing SF-6Dv2 using a discrete choice experiment in a general population in Quebec, Canada. International Journal of Health Policy and Management 13: 8404.","journal-title":"International Journal of Health Policy and Management"},{"issue":"Suppl 1","key":"2004_CR2","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s10198-013-0508-x","volume":"14","author":"AE Attema","year":"2013","unstructured":"Attema, A.E., Y. Edelaar-Peeters, M.M. Versteegh, and E.A. Stolk. 2013. Time trade-off: One methodology, different methods. The European Journal of Health Economics 14 (Suppl 1): 53\u201364.","journal-title":"The European Journal of Health Economics"},{"issue":"3_suppl","key":"2004_CR3","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1258\/jhsrp.2008.008015","volume":"13","author":"J Brazier","year":"2008","unstructured":"Brazier, J. 2008. Measuring and valuing mental health for use in economic evaluation. Journal of Health Services Research & Policy 13 (3_suppl): 70\u201375.","journal-title":"Journal of Health Services Research & Policy"},{"issue":"2","key":"2004_CR4","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/S0167-6296(01)00130-8","volume":"21","author":"J Brazier","year":"2002","unstructured":"Brazier, J., J. Roberts, and M. Deverill. 2002. The estimation of a preference-based measure of health from the SF-36. Journal of Health Economics 21 (2): 271\u2013292.","journal-title":"Journal of Health Economics"},{"issue":"4","key":"2004_CR5","doi-asserted-by":"publisher","first-page":"201","DOI":"10.2165\/00148365-200504040-00002","volume":"4","author":"J Brazier","year":"2005","unstructured":"Brazier, J., R. Akehurst, A. Brennan, P. Dolan, K. Claxton, C. McCabe, et al. 2005. Should patients have a greater role in valuing health states? Applied Health Economics and Health Policy 4 (4): 201\u2013208.","journal-title":"Applied Health Economics and Health Policy"},{"issue":"9","key":"2004_CR6","doi-asserted-by":"publisher","first-page":"705","DOI":"10.2165\/11314840-000000000-00000","volume":"27","author":"JE Brazier","year":"2009","unstructured":"Brazier, J. E., S. Dixon, and J. Ratcliffe. 2009. The role of patient preferences in cost-effectiveness analysis: A conflict of values? PharmacoEconomics 27 (9): 705\u2013712.","journal-title":"PharmacoEconomics"},{"key":"2004_CR7","volume-title":"Measuring and valuing health benefits for economic evaluation","author":"J Brazier","year":"2017","unstructured":"Brazier, J., J. Ratcliffe, J. Saloman, and A. Tsuchiya. 2017. Measuring and valuing health benefits for economic evaluation. OXFORD university press."},{"issue":"6","key":"2004_CR8","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1097\/MLR.0000000000001325","volume":"58","author":"JE Brazier","year":"2020","unstructured":"Brazier, J.E., B.J. Mulhern, J.B. Bjorner, B. Gandek, D. Rowen, J. Alonso, et al. 2020. Developing a new version of the SF-6D health state classification system from the SF-36v2: SF-6Dv2. Medical Care 58 (6): 557\u2013565.","journal-title":"Medical Care"},{"issue":"1","key":"2004_CR9","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/0168-8510(96)00822-6","volume":"37","author":"R Brooks","year":"1996","unstructured":"Brooks, R., Group E. 1996. EuroQol: The current state of play. Health Policy 37 (1): 53\u201372.","journal-title":"Health Policy"},{"key":"2004_CR10","unstructured":"Canada\u2019s Drug Agency. Guidelines for the Economic Evaluation of Health Technologies: Canada\u20144th Edition."},{"issue":"5","key":"2004_CR11","doi-asserted-by":"publisher","first-page":"S108","DOI":"10.1016\/j.jval.2011.05.012","volume":"14","author":"LN Cruz","year":"2011","unstructured":"Cruz, L. N., S. A. Camey, J. F. Hoffmann, D. Rowen, J. E. Brazier, M. P. Fleck, et al. 2011. Estimating the SF-6D value set for a population-based sample of Brazilians. Value in Health 14 (5): S108\u2013S114.","journal-title":"Value in Health"},{"issue":"7","key":"2004_CR12","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1007\/s11136-024-03649-5","volume":"33","author":"R Daroudi","year":"2024","unstructured":"Daroudi, R., H. Zeraati, T.G. Poder, R. Norman, A. Olyaeemanesh, A.A. Sari, et al. 2024. Valuing the SF-6Dv2 in the capital of Iran using a discrete choice experiment with duration. Quality of Life Research 33 (7): 1853\u20131863.","journal-title":"Quality of Life Research"},{"issue":"1","key":"2004_CR13","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12955-014-0200-6","volume":"13","author":"M Gandhi","year":"2015","unstructured":"Gandhi, M., J. Thumboo, N. Luo, H.-L. Wee, and Y.-B. Cheung. 2015. Do chronic disease patients value generic health states differently from individuals with no chronic disease? A case of a multicultural Asian population. Health and Quality of Life Outcomes 13 (1): 8.","journal-title":"Health and Quality of Life Outcomes"},{"issue":"12","key":"2004_CR14","doi-asserted-by":"publisher","first-page":"3353","DOI":"10.1007\/s11136-017-1683-5","volume":"26","author":"M Gandhi","year":"2017","unstructured":"Gandhi, M., R.S. Tan, R. Ng, S.P. Choo, W.K. Chia, C.K. Toh, et al. 2017. Comparison of health state values derived from patients and individuals from the general population. Quality of Life Research 26 (12): 3353\u20133363.","journal-title":"Quality of Life Research"},{"issue":"2","key":"2004_CR15","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s11136-010-9746-x","volume":"20","author":"SA Gerhards","year":"2011","unstructured":"Gerhards, S. A., S. M. Evers, P. W. Sabel, and M. J. Huibers. 2011. Discrepancy in rating health-related quality of life of depression between patient and general population. Quality of Life Research 20 (2): 273\u2013279.","journal-title":"Quality of Life Research"},{"key":"2004_CR16","doi-asserted-by":"crossref","unstructured":"Geuzinge, H. A., M. El Alili, J. J. Enzing, L. M. Huis, S. Knies, and G. A. de Wit. 2025. The new Dutch guideline for economic evaluations in healthcare: taking the societal perspective to the next level. Value in Health.","DOI":"10.1016\/j.jval.2025.03.002"},{"issue":"4","key":"2004_CR17","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1177\/0272989X251326600","volume":"45","author":"R Gidwani","year":"2025","unstructured":"Gidwani, R., K. W. Saylor, and L. B. Russell. 2025. Health state utility values: The implications of patient versus community ratings in assessing the value of care. Medical Decision Making 45 (4): 347\u2013357.","journal-title":"Medical Decision Making"},{"issue":"2","key":"2004_CR18","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.jval.2019.08.009","volume":"23","author":"E Goodwin","year":"2020","unstructured":"Goodwin, E., C. Green, and A. Hawton. 2020. What difference does it make? A comparison of health state preferences elicited from the general population and from people with multiple sclerosis. Value in Health 23 (2): 242\u2013250.","journal-title":"Value in Health"},{"issue":"3","key":"2004_CR19","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/S0167-6296(99)00037-5","volume":"19","author":"W Groot","year":"2000","unstructured":"Groot, W. 2000. Adaptation and scale of reference bias in self-assessments of quality of life. Journal of Health Economics 19 (3): 403\u2013420.","journal-title":"Journal of Health Economics"},{"issue":"1-2","key":"2004_CR20","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.heares.2005.04.002","volume":"207","author":"M Happich","year":"2005","unstructured":"Happich, M., and T. von Lengerke. 2005. Valuing the health state \u2018tinnitus\u2019: Differences between patients and the general public. Hearing Research 207 (1\u20132): 50\u201358.","journal-title":"Hearing Research"},{"key":"2004_CR21","volume-title":"Guide to the methods of technology appraisal 2013","author":"Health NIf","year":"2013","unstructured":"Health NIf, Excellence C. 2013. Guide to the methods of technology appraisal 2013. National Institute for Health and Care Excellence."},{"key":"2004_CR22","unstructured":"Institut f\u00fcr Qualit\u00e4t und Wirtschaftlichkeit im Gesundheitswesen (IQWiG). 2017. Allgemeine Methoden 5.0. [Available from: https:\/\/www.iqwig.de\/ueberuns\/methoden\/methodenpapier\/]. Accessed, 2025."},{"key":"2004_CR23","unstructured":"Jiang, R., J. Shaw, and A. S. Pickard, editors. 2018. Comparison of online and face-to-face valuation of the EQ-5D-5L using composite time trade off and discrete choice tasks. 40th Annual Meeting of the Society for Medical Decision Making; SMDM."},{"issue":"8","key":"2004_CR24","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1007\/s10198-020-01195-8","volume":"21","author":"M Kennedy-Martin","year":"2020","unstructured":"Kennedy-Martin, M., B. Slaap, M. Herdman, M. van Reenen, T. Kennedy-Martin, W. Greiner, et al. 2020. Which multi-attribute utility instruments are recommended for use in cost-utility analysis? A review of national health technology assessment (HTA) guidelines. The European Journal of Health Economics 21 (8): 1245\u20131257.","journal-title":"The European Journal of Health Economics"},{"issue":"1","key":"2004_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7525-9-31","volume":"9","author":"PF Krabbe","year":"2011","unstructured":"Krabbe, P.F., N. Tromp, T.J. Ruers, and P.L. van Riel. 2011. Are patients\u2019 judgments of health status really different from the general population? Health and Quality of Life Outcomes 9 (1): 31.","journal-title":"Health and Quality of Life Outcomes"},{"key":"2004_CR26","volume-title":"Guidelines for the economic evaluation of health technologies","author":"K Lee","year":"2017","unstructured":"Lee, K., C.E. McCarron, S. Bryan, D. Coyle, M. Krahn, and C. McCabe. 2017. Guidelines for the economic evaluation of health technologies. Canada: Ottawa: Canadian Agency for Drugs and Technologies in Health."},{"issue":"9","key":"2004_CR27","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1016\/j.jval.2021.02.012","volume":"24","author":"K Ludwig","year":"2021","unstructured":"Ludwig, K., J. M. Ramos-Go\u00f1i, M. Oppe, S. Kreimeier, and W. Greiner. 2021. To what extent do patient preferences differ from general population preferences? Value in Health 24 (9): 1343\u20131349.","journal-title":"Value in Health"},{"issue":"3","key":"2004_CR28","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1002\/hec.1362","volume":"18","author":"R Mann","year":"2009","unstructured":"Mann, R., J. Brazier, and A. Tsuchiya. 2009. A comparison of patient and general population weightings of EQ\u20105D dimensions. Health Economics 18 (3): 363\u2013372.","journal-title":"Health Economics"},{"issue":"8","key":"2004_CR29","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1007\/s10198-023-01657-9","volume":"25","author":"J-E Mart\u00ednez-P\u00e9rez","year":"2024","unstructured":"Mart\u00ednez-P\u00e9rez, J.-E., J.-M. Abell\u00e1n-Perpi\u00f1\u00e1n, F.-I. S\u00e1nchez-Mart\u00ednez, and J.-J. Ruiz-L\u00f3pez. 2024. A Spanish value set for the SF-6D based on the SF-12 v1. The European Journal of Health Economics: HEPAC: Health Economics in Prevention and Care 25 (8): 1333\u20131343.","journal-title":"The European Journal of Health Economics: HEPAC: Health Economics in Prevention and Care"},{"key":"2004_CR30","unstructured":"McLeod, S. 2023. Qualitative vs quantitative research: What\u2019s the difference. Simply Psychology. https:\/\/www.simplypsychology.org\/qualitative\u2026."},{"issue":"6","key":"2004_CR31","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1097\/MLR.0000000000001324","volume":"58","author":"BJ Mulhern","year":"2020","unstructured":"Mulhern, B. J., N. Bansback, R. Norman, and J. Brazier. 2020. Valuing the SF-6Dv2 classification system in the United Kingdom using a discrete-choice experiment with duration. Medical Care 58 (6): 566\u2013573.","journal-title":"Medical Care"},{"issue":"10","key":"2004_CR32","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1007\/s40273-021-01043-4","volume":"39","author":"B Mulhern","year":"2021","unstructured":"Mulhern, B., R. Norman, and J. Brazier. 2021. Valuing SF-6Dv2 in Australia using an international protocol. PharmacoEconomics 39 (10): 1151\u20131162.","journal-title":"PharmacoEconomics"},{"key":"2004_CR33","unstructured":"NICE health technology evaluation topic selection: the manual. London: National Institute for Health and Care Excellence (UK) (2022). [Available from: https:\/\/www.nice.org.uk\/process\/pmg36]."},{"issue":"4","key":"2004_CR34","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s11136-010-9609-5","volume":"19","author":"R Norman","year":"2010","unstructured":"Norman, R., M. T. King, D. Clarke, R. Viney, P. Cronin, and D. Street. 2010. Does mode of administration matter? Comparison of online and face-to-face administration of a time trade-off task. Quality of Life Research 19 (4): 499\u2013508.","journal-title":"Quality of Life Research"},{"issue":"4","key":"2004_CR35","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.jval.2014.04.002","volume":"17","author":"M Oppe","year":"2014","unstructured":"Oppe, M., N. J. Devlin, B. van Hout, P. F. Krabbe, and F. de Charro. 2014. A program of methodological research to arrive at the new international EQ-5D-5L valuation protocol. Value in Health 17 (4): 445\u2013453.","journal-title":"Value in Health"},{"key":"2004_CR36","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1007\/s40273-016-0404-1","volume":"34","author":"M Oppe","year":"2016","unstructured":"Oppe, M., K. Rand-Hendriksen, K. Shah, J.M. Ramos\u2010Go\u00f1i, and N. Luo. 2016. EuroQol protocols for time trade-off valuation of health outcomes. PharmacoEconomics 34: 993\u20131004.","journal-title":"PharmacoEconomics"},{"issue":"11","key":"2004_CR37","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.1007\/s11136-015-1018-3","volume":"24","author":"K Papageorgiou","year":"2015","unstructured":"Papageorgiou, K., K. M. Vermeulen, M. J. Schroevers, A. M. Stiggelbout, E. Buskens, P. F. Krabbe, et al. 2015. Do individuals with and without depression value depression differently? And if so, why? Quality of Life Research 24 (11): 2565\u20132575.","journal-title":"Quality of Life Research"},{"issue":"2","key":"2004_CR38","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1111\/j.1524-4733.2009.00610.x","volume":"13","author":"Y Peeters","year":"2010","unstructured":"Peeters, Y., and A. M. Stiggelbout. 2010. Health state valuations of patients and the general public analytically compared: A meta-analytical comparison of patient and population health state utilities. Value in Health 13 (2): 306\u2013309.","journal-title":"Value in Health"},{"issue":"4","key":"2004_CR39","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1007\/s10198-012-0421-8","volume":"14","author":"AS Pickard","year":"2013","unstructured":"Pickard, A.S., R. Tawk, and J.W. Shaw. 2013. The effect of chronic conditions on stated preferences for health. The European Journal of Health Economics 14 (4): 697\u2013702.","journal-title":"The European Journal of Health Economics"},{"key":"2004_CR40","doi-asserted-by":"publisher","first-page":"117632","DOI":"10.1016\/j.socscimed.2024.117632","volume":"366","author":"TG Poder","year":"2025","unstructured":"Poder, T. G., and H. Ameri. 2025. A new SF-6Dv2 value set based on a hybrid model using SG, cTTO, and DCE data. Social Science & Medicine 366:117632.","journal-title":"Social Science & Medicine"},{"issue":"9","key":"2004_CR41","doi-asserted-by":"publisher","first-page":"e14647","DOI":"10.1097\/MD.0000000000014647","volume":"98","author":"TG Poder","year":"2019","unstructured":"Poder, T. G., N. Carrier, N. McFadden, and M. Pavic. 2019. Health utilities in cancer patients: A study protocol for a prospective, longitudinal cohort using online survey. Medicine 98 (9): e14647.","journal-title":"Medicine"},{"issue":"3","key":"2004_CR42","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.jval.2016.10.012","volume":"20","author":"JM Ramos-Go\u00f1i","year":"2017","unstructured":"Ramos-Go\u00f1i, J. M., M. Oppe, B. Slaap, J. J. Busschbach, and E. Stolk. 2017. Quality control process for EQ-5D-5L valuation studies. Value in Health 20 (3): 466\u2013473.","journal-title":"Value in Health"},{"issue":"1","key":"2004_CR43","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1177\/0272989X14557178","volume":"35","author":"D Rowen","year":"2015","unstructured":"Rowen, D., B. Mulhern, S. Banerjee, R. Tait, C. Watchurst, S. C. Smith, et al. 2015. Comparison of general population, patient, and carer utility values for dementia health states. Medical Decision Making 35 (1): 68\u201380.","journal-title":"Medical Decision Making"},{"issue":"9","key":"2004_CR44","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1007\/s40273-022-01159-1","volume":"40","author":"D Rowen","year":"2022","unstructured":"Rowen, D., C. Mukuria, and E. McDool. 2022. A systematic review of the methodologies and modelling approaches used to generate international EQ-5D-5L value sets. PharmacoEconomics 40 (9): 863\u2013882.","journal-title":"PharmacoEconomics"},{"issue":"7","key":"2004_CR45","doi-asserted-by":"publisher","first-page":"A480","DOI":"10.1016\/j.jval.2016.09.770","volume":"19","author":"VP Rupel","year":"2016","unstructured":"Rupel, V. P., and M. O. Marko. 2016. Should patients estimate health related quality of life? The results of empirical study. Value in Health 19 (7): A480.","journal-title":"Value in Health"},{"issue":"3","key":"2004_CR46","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1046\/j.1369-6513.2002.00182.x","volume":"5","author":"DL Schwappach","year":"2002","unstructured":"Schwappach, D. L. 2002. Resource allocation, social values and the QALY: A review of the debate and empirical evidence. Health Expectations 5 (3): 210\u2013222.","journal-title":"Health Expectations"},{"issue":"3","key":"2004_CR47","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s40258-023-00865-x","volume":"22","author":"T Shiroiwa","year":"2024","unstructured":"Shiroiwa, T., and T. Fukuda. 2024. Are web-based valuation surveys for preference-based measures as reliable as face-to-face surveys? TTO, DCE and DCE with duration. Applied Health Economics and Health Policy 22 (3): 391\u2013400.","journal-title":"Applied Health Economics and Health Policy"},{"issue":"2","key":"2004_CR48","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s11136-024-03830-w","volume":"34","author":"T Shiroiwa","year":"2025","unstructured":"Shiroiwa, T., Y. Yamamoto, T. Murata, B. Mulhern, J. Bjorner, J. Brazier, et al. 2025. Valuation survey for SF-6Dv2 in Japan based on the international protocol. Quality of Life Research 34 (2): 445\u2013455.","journal-title":"Quality of Life Research"},{"issue":"11","key":"2004_CR49","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1016\/S0277-9536(99)00045-3","volume":"48","author":"MA Sprangers","year":"1999","unstructured":"Sprangers, M.A., and C.E. Schwartz. 1999. Integrating response shift into health-related quality of life research: A theoretical model. Social Science & Medicine 48 (11): 1507\u20131515.","journal-title":"Social Science & Medicine"},{"issue":"1","key":"2004_CR50","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1093\/bmb\/ldr001","volume":"97","author":"E Stamuli","year":"2011","unstructured":"Stamuli, E. 2011. Health outcomes in economic evaluation: Who should value health? British Medical Bulletin 97 (1): 197\u2013210.","journal-title":"British Medical Bulletin"},{"issue":"1","key":"2004_CR51","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/j.1524-4733.2007.00216.x","volume":"11","author":"AM Stiggelbout","year":"2008","unstructured":"Stiggelbout, A.M., and E. De Vogel\u2010Voogt. 2008. Health state utilities: A framework for studying the gap between the imagined and the real. Value in Health 11 (1): 76\u201387.","journal-title":"Value in Health"},{"key":"2004_CR52","doi-asserted-by":"publisher","first-page":"117073","DOI":"10.1016\/j.socscimed.2024.117073","volume":"354","author":"T Sullivan","year":"2024","unstructured":"Sullivan, T., G. McCarty, F. Ombler, R. Turner, B. Mulhern, and P. Hansen. 2024. Creating an SF-6Dv2 social value set for New Zealand. Social Science & Medicine 354:117073.","journal-title":"Social Science & Medicine"},{"key":"2004_CR53","doi-asserted-by":"publisher","first-page":"117001","DOI":"10.1016\/j.socscimed.2024.117001","volume":"351","author":"M Tour\u00e9","year":"2024","unstructured":"Tour\u00e9, M., and T. G. Poder. 2024. Differences in health utilities between cancer patients and the general population: The case of Quebec using the SF-6Dv2. Social Science & Medicine 351:117001.","journal-title":"Social Science & Medicine"},{"issue":"8","key":"2004_CR54","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1097\/MLR.0000000000001880","volume":"61","author":"M Tour\u00e9","year":"2023","unstructured":"Tour\u00e9, M., M. Pavic, and T. G. Poder. 2023. Second version of the short form 6-dimension value set elicited from patients with breast and colorectal cancer: A hybrid approach. Medical Care 61 (8): 536\u2013545.","journal-title":"Medical Care"},{"issue":"4","key":"2004_CR55","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.2307\/2937956","volume":"106","author":"A Tversky","year":"1991","unstructured":"Tversky, A., and D. Kahneman. 1991. Loss aversion in riskless choice: A reference-dependent model. The Quarterly Journal of Economics 106 (4): 1039\u20131061.","journal-title":"The Quarterly Journal of Economics"},{"key":"2004_CR56","unstructured":"(TLV) TDaPBA. General Guidelines for Economic Evaluations from the Pharmaceutical Benefits Board (LFNAR2003:2). Stockholm: The Dental and Pharmaceutical Benefits Agency."},{"key":"2004_CR57","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.socscimed.2016.07.043","volume":"165","author":"M Versteegh","year":"2016","unstructured":"Versteegh, M., and W. Brouwer. 2016. Patient and general public preferences for health states: A call to reconsider current guidelines. Social Science & Medicine 165:66\u201374.","journal-title":"Social Science & Medicine"},{"issue":"1","key":"2004_CR58","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1080\/13696998.2023.2195753","volume":"26","author":"L Wang","year":"2023","unstructured":"Wang, L., and T. G. Poder. 2023. A systematic review of SF-6D health state valuation studies. Journal of Medical Economics 26 (1): 584\u2013593.","journal-title":"Journal of Medical Economics"},{"issue":"3","key":"2004_CR59","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s40271-014-0059-y","volume":"7","author":"P Wang","year":"2014","unstructured":"Wang, P., E. Tai, J. Thumboo, H. J. Vrijhoef, and N. Luo. 2014. Does diabetes have an impact on health-state utility? A study of Asians in Singapore. The Patient - Patient-Centered Outcomes Research 7 (3): 329\u2013337.","journal-title":"The Patient - Patient-Centered Outcomes Research"},{"issue":"1","key":"2004_CR60","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1093\/bmb\/ldq033","volume":"96","author":"SJ Whitehead","year":"2010","unstructured":"Whitehead, S.J., and S. Ali. 2010. Health outcomes in economic evaluation: The QALY and utilities. British Medical Bulletin 96 (1): 5\u201321.","journal-title":"British Medical Bulletin"},{"issue":"5","key":"2004_CR61","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s40273-020-00997-1","volume":"39","author":"J Wu","year":"2021","unstructured":"Wu, J., S. Xie, X. He, G. Chen, G. Bai, D. Feng, et al. 2021. Valuation of SF-6Dv2 health states in China using time trade-off and discrete-choice experiment with a duration dimension. PharmacoEconomics 39 (5): 521\u2013535.","journal-title":"PharmacoEconomics"}],"container-title":["The European Journal of Health Economics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10198-026-02004-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10198-026-02004-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10198-026-02004-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T17:02:13Z","timestamp":1792774933000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10198-026-02004-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,23]]},"references-count":61,"alternative-id":["2004"],"URL":"https:\/\/doi.org\/10.1007\/s10198-026-02004-4","relation":{},"ISSN":["1618-7598","1618-7601"],"issn-type":[{"value":"1618-7598","type":"print"},{"value":"1618-7601","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,23]]},"assertion":[{"value":"18 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of our institutional ethics committees (Comit\u00e9 d\u2019\u00e9thique de la recherche of the CIUSSS de l\u2019Estrie\u2013 CHUS #2017\u20131490 and Comit\u00e9 d\u2019\u00e9thique de la recherche en sciences et en sant\u00e9 de l\u2019Universit\u00e9 de Montr\u00e9al #2024\u20135457).","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}